Emmaus Life Sciences, Inc.
EMMA· OTC
Emmaus Life Sciences, Inc.
- Close
- Aug 31, 2026 · -25.00%
- Market cap
- $4.21M
- 70.19M shares
- Filings
- 1,003
Price
Aug 31, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $12,453,000 | reported | |
| FY 2024 | 2024-12-31 | $16,653,000 | reported | |
| FY 2023 | 2023-12-31 | $29,597,000 | reported | |
| FY 2022 | 2022-12-31 | $18,390,000 | reported | |
| FY 2021 | 2021-12-31 | $20,610,000 | reported | |
| FY 2020 | 2020-12-31 | $23,167,000 | reported | |
| FY 2019 | 2019-12-31 | $22,752,000 | reported | |
| FY 2018 | 2018-12-31 | $16,459,000 | reported |
Emmaus Life Sciences, Inc. · CIK 822370 · Engraved from SEC EDGAR
